Skip to Content

Discoveries

navigating the future
of biologics

Welcome to Discoveries at Bora Biologics, your destination for the latest insights and knowledge to keep you at the forefront of biopharmaceutical innovation. Here, you’ll find a curated collection of educational resources—press releases, expert insights, case studies, and publications—crafted to inspire and inform you on your journey from molecule to market.

image description
image description

What’s New at Bora Biologics

Publications

Scaling Analytical RP-HPLC to Semi-Preparative for Fractionation and Characterization of Pegfilgrastim Oxidized Variants

View Now
View Now
Publications

Characterization of Product Related Variants in Therapeutic Monoclonal Antibodies

View Now
View Now
Publications

Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC Method

View Now
View Now
Publications

Dimethyl Sulfoxide as a Gas Phase Charge-reducing Agent for the Determination of PEGylated Proteins’ Intact Mass

View Now
View Now
Publications

Comparative Analysis of Herceptin N-Linked Glycosylation by HILIC-FLD and LC-MS/MS Methods

View Now
View Now
Publications

Characterization of PEGylation Sites in Neulasta and a Biosimilar Candidate with a Combined Fragmentation Strategy in Mass Spectrometry Analysis

View Now
View Now
preloader
image description image description image description image description image description

Bora Biologics

the logical choice

Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.

Partner with us

Client-Centric

100% commitment to supporting your success

We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

Experience

14 years developing & manufacturing biologics

We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

Expertise

125 seasoned scientists & regulatory professionals

Our team exudes deep knowledge and specialized skills, with over 50% holding advanced degrees. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

Commercial-Ready

US FDA registered GMP manufacturing facility

We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

Allied

access to global CDMO resources

Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.